"18"^^ . . . . "NCT00869206" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . . "klinisch onderzoek"@nl . . . "ensayo cl\u00EDnico"@es . . . . . . . . . "1822"^^ . "Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement"@en . . . . . . . . . . . . "2009-03-01T00:00:00Z"^^ . . . . . . . . "clinical trial"@en . . . . . . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . "A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer"@en . . . . "Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement"@en . . . "Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement"@en . "2014-06-01T00:00:00Z"^^ . .